NASDAQ
CNBX Pharmaceuticals Inc. (CNBX) has a free cash flow growth of 35.56% as of Friday, May 29, 2026. This represents a 364.13% increase compared to its 12-month average of -13.46%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.